Wen, Jing-jing
18909  Ergebnisse:
Personensuche X
?
1

Additional file 3 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/dataset/Additional_file_3_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110847.  , 2021
 
?
2

Additional file 4 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/dataset/Additional_file_4_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110850.  , 2021
 
?
 
?
4

Additional file 1 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/dataset/Additional_file_1_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110841.  , 2021
 
?
6

Additional file 7 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/journal_contribution/Additional_file_7_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110859.  , 2021
 
?
7

Additional file 5 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/journal_contribution/Additional_file_5_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110853.  , 2021
 
?
8

Additional file 8 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/journal_contribution/Additional_file_8_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110862.  , 2021
 
?
9

Additional file 6 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/journal_contribution/Additional_file_6_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110856.  , 2021
 
?
 
?
11

Additional file 2 of CircEAF2 counteracts Epstein-Barr viru..:

Chen-xing Zhao (11781113) ; Zi-xun Yan (11781116) ; Jing-jing Wen (11781119)...
https://figshare.com/articles/journal_contribution/Additional_file_2_of_CircEAF2_counteracts_Epstein-Barr_virus-positive_diffuse_large_B-cell_lymphoma_progression_via_miR-BART19-3p_APC_-catenin_axis/17110844.  , 2021
 
?
 
?
14

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refracto..:

Qin, Chuan ; Tian, Dai-Shi ; Zhou, Luo-Qi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810610/.  , 2023
 
?
15

The triglyceride-glucose index as a potential protective fa..:

Meng, Xiangbin ; Gao, Jun ; Zhang, Kuo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308672/.  , 2023
 
1-15